ArticlePLoS medicine2026

Cost-effectiveness of pirfenidone for patients with cancer and grade 2 or grade 3 radiation-induced lung injury: A modeling study.

Qiu-Yi Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.